Marijke Haas

Title: Marijke Haas: Innovator in Angiotensin Analog Research

Introduction

Marijke Haas is a notable inventor based in Groningen, Netherlands. She has made significant contributions to the field of biochemistry, particularly in the development of cyclic angiotensin analogs. Her work focuses on creating innovative solutions for therapeutic applications, especially in the treatment of hypertension.

Latest Patents

Marijke Haas holds a patent for her invention titled "Cyclic angiotensin analogs." This invention relates to analogs of angiotensins, specifically cyclized analogs that exhibit Ang(1-8) agonistic or antagonistic activity. Additionally, her work includes cyclized Ang(1-7) analogs that display improved proteolytic resistance compared to their linear counterparts. The cyclic angiotensin peptide analog comprises a thioether-bridge linkage between the amino acids corresponding to positions Tyr and Pro in naturally occurring Angiotensin. The analogs are intended for therapeutic use, particularly in managing hypertension.

Career Highlights

Marijke Haas is associated with Applied Nanosystems B.V., where she continues to advance her research in angiotensin analogs. Her innovative approach has garnered attention in the scientific community, contributing to the understanding of peptide analogs and their potential applications in medicine.

Collaborations

Marijke collaborates with notable colleagues, including Leonardus Dorothea Kluskens and Anneke Kuipers. Their combined expertise enhances the research and development of new therapeutic strategies.

Conclusion

Marijke Haas is a pioneering inventor whose work on cyclic angiotensin analogs holds promise for improving therapeutic options for hypertension. Her contributions to the field exemplify the impact of innovative research in biochemistry.